Browse: Companies | People | Financial Organizations
Home > Companies > Parasol Therapeutics

General Information
edit

CategoryBioTech
Employees
DescriptionInfluenza Research

Offices
edit

Funding
edit

Series A, 5/09
Polaris Venture Partners
Flagship Ventures
Lux Capital
$3.25M

Tags
edit

influenza, flu, disease-control

Parasol Therapeutics
edit

Parasol Therapeutics does research on influenza diagnostics and treatment. They were in seed/stealth stage as of June 2009.

Milestones
edit

  • Received $3.25M in Series A funding. (5/10/09)
    Posted 6/23/09 at 12:36pm

Videos

Screenshots
edit

Sources

  1. Parasol Therapeutics, Inc.: Series A $3.25M (onbiovc.com) [edit]
Edit This Page
Last Edited 6/23/09

Revision History RSS Picture

Recent Incoming Links

External Links
edit

Embed Widget

More

CrunchBase API

JSON Representation of this page.
More API docs »

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy